These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 37235361

  • 1. Use of Botulinum Toxin as a Treatment of Hemiplegic Shoulder Pain Syndrome: A Randomized Trial.
    de Melo Carvalho Rocha E, Riberto M, da Ponte Barbosa R, Geronimo RMP, Menezes-Junior M.
    Toxins (Basel); 2023 May 11; 15(5):. PubMed ID: 37235361
    [Abstract] [Full Text] [Related]

  • 2. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM.
    Am J Phys Med Rehabil; 2012 Dec 11; 91(12):1007-19. PubMed ID: 23064478
    [Abstract] [Full Text] [Related]

  • 3. Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tan B, Jia L.
    Stroke; 2021 Dec 11; 52(12):3759-3767. PubMed ID: 34470492
    [Abstract] [Full Text] [Related]

  • 4. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
    Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, Escalada F, Espadaler JM.
    J Rehabil Med; 2007 Jul 11; 39(6):440-7. PubMed ID: 17624477
    [Abstract] [Full Text] [Related]

  • 5. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.
    Yelnik AP, Colle FM, Bonan IV, Vicaut E.
    J Neurol Neurosurg Psychiatry; 2007 Aug 11; 78(8):845-8. PubMed ID: 17088333
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH, Neo JJ, Chua KS.
    Clin Rehabil; 2007 Jan 11; 21(1):28-35. PubMed ID: 17213238
    [Abstract] [Full Text] [Related]

  • 7. Effect of ultrasound-guided injection of botulinum toxin type A into shoulder joint cavity on shoulder pain in poststroke patients: study protocol for a randomized controlled trial.
    Zheng P, Shi Y, Qu H, Han ML, Wang ZQ, Zeng Q, Zheng M, Fan T.
    Trials; 2024 Jun 27; 25(1):418. PubMed ID: 38937804
    [Abstract] [Full Text] [Related]

  • 8. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May 27; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Botulinum Toxin A in Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-analysis.
    Xie HM, Guo TT, Sun X, Ge HX, Chen XD, Zhao KJ, Zhang LN.
    Arch Phys Med Rehabil; 2021 Sep 27; 102(9):1775-1787. PubMed ID: 33454279
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin injection of the subscapularis muscle.
    Unlu E, Sen T, Umay E, Bal B, Elhan A, Cakci A.
    J Clin Neurosci; 2010 Oct 27; 17(10):1265-6. PubMed ID: 20591673
    [Abstract] [Full Text] [Related]

  • 11. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP, Pinto D, Gorayeb M, Jacinto J.
    Top Stroke Rehabil; 2018 Apr 27; 25(3):194-202. PubMed ID: 29322885
    [Abstract] [Full Text] [Related]

  • 12. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK.
    Holmes RJ, Connell LA.
    Disabil Rehabil; 2019 Mar 27; 41(6):720-726. PubMed ID: 29126361
    [Abstract] [Full Text] [Related]

  • 13. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide.
    Lim JY, Koh JH, Paik NJ.
    Stroke; 2008 Jan 27; 39(1):126-31. PubMed ID: 18048857
    [Abstract] [Full Text] [Related]

  • 14. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin a in the subscapular muscle.
    Yelnik AP, Colle FM, Bonan IV.
    Eur Neurol; 2003 Jan 27; 50(2):91-3. PubMed ID: 12944713
    [Abstract] [Full Text] [Related]

  • 15. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.
    J Rehabil Med; 2010 Jan 27; 42(1):81-9. PubMed ID: 20111849
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.
    Ploumis A, Varvarousis D, Konitsiotis S, Beris A.
    Disabil Rehabil; 2014 Jan 27; 36(4):313-8. PubMed ID: 23672209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.
    J Am Med Dir Assoc; 2012 Jun 27; 13(5):477-84. PubMed ID: 22521630
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.